UPs-4T1/EPB nanovaccine in combination with STING agonist (5,6-dimethylxanthenone-4-acetic acid; DMXAA) resulted in complete tumor regression and complete elimination of the metastases in the majority of mice with drug-resistant and metastatic breast cancer. Here, STING1 is linked to neoplasm.